Overview of Last Week
FreshMatter
Universal Globe's Nephrology Specialty Platform Acquires Five Medical InstitutionsYuan Da Liu's Yiwu Dao Yi Integrated Traditional Chinese and Western Medicine Clinic Opens
- Haiwang Xingchen's First Comprehensive Clinic in Shenzhen Opens
Samsung Medical's High-Premium Acquisition of 6 Rehabilitation Hospitals Declared Failed
- Implementation of the New "Nine National Provisions," Modification of Shanghai and Shenzhen Listing Standards
Yingkang Yisheng, under Haier, launches "Haiyi Hui," building China's first medical engineering technology industrialization platform
- 8 Years, 5 Cities, 15 Hospitals: ProDent Dental Clinic Enters Western Guangdong for the First Time
Tug Healthcare Completes Nearly 200 Million Yuan in Series B Financing
- Qianhai to Add 3 New International Hospitals This Year
Three Hospital Presidents Investigated on the Same Day
- China's State Administration for Market Regulation "Swords Out" on Medical Advertising: Special Oversight of Six Major Issues
Shanghai Clarifies the Construction Standards for Grassroots Workstations of Municipal Famous TCM Studios
- Boehringer Ingelheim Exits Stroke Rehabilitation Business in China to Focus on Oncology
Six Ministries Focus on Six Key Areas in Overhauling Medical Insurance Funds
- Johnson & Johnson Acquires Cardiovascular Device Company for $13.1 Billion
Clinic Project Services
One-Stop Service for the Construction and Operation of Internet Hospitals
Universal Globe's Nephrology Specialty Platform Acquires Five Medical Institutions
On April 13, the nephrology specialty business platform under General Technology Universal Medical ––Global Yuelley Medical Technology(Tianjin) Co., Ltd. (hereinafter referred to as "Global Yuelley") has successfully completed the signing of the acquisition cooperation agreement with Hainan Compass Rose Hospital Management Co., Ltd. (hereinafter referred to as "Hainan Compass Rose"). This acquisition marks that Universal Medical's development in the nephrology specialty field has officially entered the scale era. According to the cooperation agreement, Global Yuelley will acquire all the five hemodialysis centers under Hainan Compass Rose located in Chifeng of Inner Mongolia, Laiyang of Shandong, and Xinmi, Yingyang, and Zhengzhou of Henan. After the completion of the acquisition, Global Yuelley will hold 100% equity of these five hemodialysis centers, further expanding its market share in the nephrology specialty field.(General Technology Global Medical Information)
Yuan Da Liu's Yiwu Dao Yi Integrated Traditional Chinese and Western Medicine Clinic Opens
April 13,Yuan Da Liu's Dao Yi Integrated Chinese and Western Medicine ClinicOpened in Yiwu. Yuan Da Chinese Medicine Chain was founded in Shenzhen in 2018 as an integrated Chinese medicine chain service platform that operates Chinese medicine clinics, Chinese medicine halls, Chinese medicine dietary therapy, health education, and sales of comprehensive health products. Its origins can be traced back to Yuan Da Liu’s Chinese Medicine in 1851. Adopting a "1+N" dual-engine development model of Chinese medicine clinics and Chinese medicine specialty pain therapy centers, it currently covers franchised chains across 16 cities in China and has established more than 100 city operation centers.(Yuanda Pain Management Center News)
Haiwang Xingchen's First Comprehensive Clinic in Shenzhen Opens
April 13,Haiwang Xingchen Donghuan Yi Road ClinicThe opening marks the first comprehensive outpatient department established in the Shenzhen area. Haiwang Xingchen Pharmaceutical was founded in 1995, with its headquarters located in Shenzhen, serving as a leading enterprise in China's pharmaceutical chain pharmacy industry. It operates nearly 5,000 health pharmacies across more than 70 cities in China. Currently, it has opened over six chain clinic institutions in Shenzhen.(Shenzhen Haiwang Xingchen News)
Samsung Medical's High-Premium Acquisition of 6 Rehabilitation Hospitals Declared Failed
April 12,Samsung MedicalAnnouncement on the Termination of Hospital Equity Acquisition and Related Party Transactions. The company held the eleventh meeting of the sixth board of directors, which reviewed and approved the "Proposal on Terminating the Equity Acquisition of Six Target Hospitals and Related Party Transactions." It stated that due to some of the target hospitals not being profitable in 2023, and considering the cost of acquisition funds and acquisition risks comprehensively, the company decided to terminate the acquisition of the equity of six target hospitals after careful consideration. As the company has decided to terminate this hospital equity acquisition, it will no longer respond to the issues raised in the inquiry letter from the Shanghai Stock Exchange. Previously, the targets Samsung Healthcare intended to acquire were related assets of six rehabilitation hospitals: Taizhou Mingzhou Rehabilitation Hospital Co., Ltd., Nanchang Mingzhou Ganbei Rehabilitation Hospital Co., Ltd., Hangzhou Mingzhou Guniangqiao Rehabilitation Hospital Co., Ltd., Nanjing Ruixia Mingzhou Rehabilitation Hospital Co., Ltd., Shanghai Mingzhou Yongjia Rehabilitation Hospital Co., Ltd., and Changshu Mingzhou Rehabilitation Hospital Co., Ltd.(Samsung Medical News)
Implementation of the New "Nine National Provisions," Modification of Shanghai and Shenzhen Listing Standards
On April 12, the Shanghai and Shenzhen stock exchanges released a draft of the stock listing rules for public comment, raising the listing thresholds for the Shanghai and Shenzhen Main Boards and the Growth Enterprise Market (GEM). Specifically, the net profit indicator in the first set of IPO listing standards for the Shanghai and Shenzhen Main Boards was increased from 60 million yuan to 100 million yuan in the most recent year; for the GEM, the first set of IPO listing standards added a threshold requiring a net profit of no less than 60 million yuan in the most recent year. For companies on the Sci-Tech Innovation Board (STAR Market) and the Beijing Stock Exchange, the IPO financial conditions remained unchanged, but regulators imposed higher requirements on the technological innovation attributes of STAR Market enterprises.(News from the National Business Daily)
Ying Kang Yi Sheng, under Haier, launches "Hai Yi Hui," building China's first medical engineering technology industrialization platform
On April 10, Haier Group's large health ecosystem brand ——Ying Kang Yi ShengLed the establishment of "Haiyi Hui," the first medical-engineering scientific innovation industrialization platform in China. The "Haiyi Hui" platform was initiated by Yingcare, in collaboration with the Chinese Research Hospital Association, Shandong Industrial Technology Research Institute, and Hanyuan Capital. The platform focuses on innovative fields such as brain science, life science, women's health, blood ecosystem, precision oncology diagnosis and treatment, and medical care rehabilitation, specializing in accelerating the transformation and incubation of high-end innovative pharmaceuticals and medical devices' research results. Currently, Haiyi Hui has formed a polymeric ecosystem that integrates industry, academia, research, and finance, and is actively promoting the transformation of basic research into clinical applications.(News from Yingkang Yisheng)
8 Years, 5 Cities, 15 Hospitals: ProDent Dental Clinic Enters Western Guangdong for the First Time
April 10,Polle OralZhanjiang Jingji City Main Hospital Opens: The 15th Branch of Polaris Dental, Covering Nearly 4,000 Square Meters with a "Digital Implant Solution Design Center," A Fully Digital Oral Healthcare Institution. Founded in 2016, Polaris Dental Operates 15 Chain Clinics Across Guangxi, Guizhou, and Guangdong Provinces.(Zhanjiang Bole Dental Brand Chain News)
Tug Healthcare Completes Nearly 200 Million Yuan in Series B Financing
April 10, NanjingTug MedicalTech Co., Ltd. ("Tuge Medical" for short) has completed a new round of financing, raising nearly 200 million RMB. This round of financing was jointly led by LongRiver Jiangyuan Investment and Dongzheng Innovation, with several institutions following the investment. The funds will be used for the commercial promotion of minimally invasive surgical imaging equipment and continued investment in the research and development of new products, ensuring further improvement of the domestic and international marketing networks and channels, as well as continuous enhancement and iterative updates of the products, further strengthening the company's comprehensive competitiveness in the field of minimally invasive surgical endoscopy. Nanjing Tuge Medical Technology Co., Ltd., established in 2018, focuses on medical endoscopic imaging systems and digitally intelligent operating rooms. It is the first to break the foreign monopoly in the field of 4K 3D ICG all-in-one electronic endoscopic camera systems, which represent the highest technological content at present, and is also the first company in China to obtain a registration certificate.(Artery Network News)
Qianhai to Add 3 New International Hospitals This Year
On April 10, the Qianhai Administration announced that Qianhai will add this yearShenzhen Qianhai Taikang Hospital、CMBC Taizi Bay Hospital、Shenzhen Qianhai Sen Port Dental HospitalThree international hospitals. In addition, multiple "connectivity" initiatives for cross-border medical services between Shenzhen and Hong Kong have been implemented in Qianhai, including "Physician Connect," "Pharmaceuticals and Medical Devices Connect," and "Medical Insurance Connect." Currently, Shenzhen Qianhai Taikang Hospital has been basically completed and is planned to open this year. Merchants Lippo Prince’s Bay Hospital will be built following the "small comprehensive, strong specialized" model, with a focus on high-end health management, women and children's healthcare, and other specialties. Shenzhen Qianhai Senport Dental Hospital, the first purely Hong Kong-funded hospital in Qianhai, will collaborate deeply with Hong Kong’s Ren’an Hospital to introduce Hong Kong dental specialists for cross-border practice in Qianhai, with operations expected to commence in the second half of this year.(Qianhai Financial City Post News)
Three Hospital Presidents Investigated on the Same Day
On April 9, at least three hospital presidents were officially announced to be under investigation, including the president of a tertiary hospital. According to the Heilongjiang Provincial Commission for Discipline Inspection and Supervision, Chen Hong, the Party Secretary and President of the Heilongjiang Academy of Traditional Chinese Medicine, is suspected of serious disciplinary violations and illegal activities, and is currently under disciplinary review and supervision investigation by the Heilongjiang Provincial Commission for Discipline Inspection and Supervision. Chen Hong has long been engaged in research on the efficacy and mechanisms of traditional Chinese medicine treatment for tumors, and has held positions at Qiqihar Hospital of Traditional Chinese Medicine, Qiqihar First Hospital, and Heilongjiang Hospital of Traditional Chinese Medicine. According to the Suzhou Municipal Commission for Discipline Inspection and Supervision in Anhui Province, He Xin, the Deputy Secretary of the Party General Branch and President of Suzhou Third People's Hospital, is suspected of serious disciplinary violations and illegal activities, and is currently under disciplinary review and supervision investigation by the Yongqiao District Commission for Discipline Inspection and Supervision. The Anqing Municipal Commission for Discipline Inspection and Supervision in Anhui Province announced that Jiang Changzhou, Vice Chairman of the Wangjiang County Committee of the Chinese People's Political Consultative Conference in Anqing City and former president of the county hospital, is suspected of serious official misconduct and is currently under investigation by the Anqing Municipal Supervisory Commission.(China News Service)
China's State Administration for Market Regulation "Cracks Down" on Medical Advertisements Special Supervision of Six Major Chaos
On April 9, the State Administration for Market Regulation (SAMR) officially issued the "Special Action on Advertising Supervision in Key People's Livelihood Areas by SAMR," organizing a nationwide special action on advertising supervision in key people’s livelihood areas from April to November 2024. 1. Maintain a high-pressure and severe crackdown on illegal practices in medical aesthetics advertisements.2. Strictly investigate and punish "miracle doctor" and "miracle drug" advertisements, severely penalizing the disguised publication of medical, pharmaceutical, medical device, and health food advertisements under the guise of health education.3. Prevent the promotion of health food as having curative effects and regular food as having functional benefits.4. Legally investigate false and illegal advertisements for myopia control products, continuously rectifying the confusion between true and false myopia and the misleading use of terms such as "rehabilitation," "recovery," "reduce diopter," "myopia cure," "myopia conqueror," and "diopter restoration" in advertisements targeting consumers.5. Strengthen the regulation of advertisements for daily chemical products like cosmetics and disinfectants, and vigorously address illegal behaviors that explicitly or implicitly claim these products have medical effects.6. Effectively standardize all types of training advertisements.(News from the Market Supervision Administrator)
Shanghai Clarifies the Construction Standards for Grassroots Workstations of Municipal Famous TCM Studios
On April 8, the Shanghai Municipal Health Commission and the Shanghai Administration of Traditional Chinese Medicine issued the "Construction Standards for Grassroots Workstations of Shanghai's Municipal Famous TCM Practitioners' Studios." On the basis of ensuring organizational support, further requirements have been proposed regarding personnel management, information technology construction, academic inheritance, and medical specialties. Among these, the first batch of 100 grassroots workstations of municipal famous TCM practitioners’ studios in Shanghai has already begun construction. According to the "Construction Standards," each workstation must have a team with no fewer than three members. An expert team led by renowned TCM experts from the studio will be stationed at the workstation to conduct diagnosis and treatment, teaching, free clinics, lectures, and professional training. Renowned municipal TCM practitioners or heads of TCM studios are required to visit no less than twice per month, with each visit lasting at least half a day. The workstations are also expected to establish at least one specialized disease clinic and develop at least one area of treatment expertise.(Information from the Shanghai Municipal Health Commission)
Boehringer Ingelheim Exits Stroke Rehabilitation Business in ChinaFocus Shift to Tumors
April 8,China BioPharmaceutical(1177.HK) and a well-known German pharmaceutical companyBoehringer Ingelheim(Boehringer Ingelheim) announced the signing of a strategic cooperation agreement. Both parties will rely on their respective strengths and resources to jointly research, develop, and commercialize Boehringer Ingelheim's oncology pipeline in mainland China. According to the terms of the agreement, this strategic cooperation covers multiple assets of Boehringer Ingelheim in clinical stages, including three assets in clinical development: Brigimadlin, Zongertinib, and the DLL3/CD3 bispecific T-cell engager, as well as several early-stage clinical assets. Previously, on April 1st, under Boehringer Ingelheim’s brand “Jida Rehabilitation"Announced on the official website that due to the company's strategic layout adjustment, it has decided to withdraw from the stroke rehabilitation business in China.(Nanjing Release Message)
Six Ministries Focus on Six Key Areas in Rectifying Medical Insurance Funds
On April 8, the National Healthcare Security Administration, Supreme People's Court, Supreme People's Procuratorate, Ministry of Public Security, Ministry of Finance, and National Health Commission jointly convened the 2024 National Special Rectification Work Conference on Illegal and Irregular Issues of Medical Insurance Funds. The conference comprehensively analyzed the situation faced by medical insurance funds and arranged six key tasks for 2024. First, taking strong actions to crack down on fraudulent activities such as fake diagnosis and treatment, reselling of medical insurance drugs, and false drug purchases. Second, strengthening unannounced inspections. Third, building three big data supervision barriers: pre-event reminders, mid-event reviews, and post-event oversight. Fourth, improving long-term supervision mechanisms from aspects like technology, capability, and management. Fifth, enhancing inter-departmental collaboration and vertical coordination. Sixth, reinforcing discipline construction.(National Healthcare Security Administration News)
Johnson & Johnson Acquires a Cardiovascular Device Company for $13.1 Billion
April 5,Johnson & JohnsonJohnson & Johnson and Shockwave Medical jointly announced that Johnson & Johnson will acquire all outstanding shares of Shockwave for $335 per share in cash, valuing the deal at approximately $13.1 billion (approximately RMB 94.8 billion). Johnson & Johnson intends to finance the transaction through a combination of cash and debt. The deal is expected to close by mid-2024, subject to approval by Shockwave shareholders and other closing conditions. Founded in California, USA, in 2009, Shockwave focuses on developing products for the treatment of calcified cardiovascular diseases and pioneered the "shockwave balloon catheter" product globally.(Data Bao Message)
?Click the image to register for learning
?Click the image to consult immediately
JoinStar Member of the Diagnostic Lock IndustryFree Unlock2024 The 5th China Diagnostic ExpoVideo Playback?
